dc.contributor.author |
Kayabas, Hatice |
|
dc.contributor.author |
Devran Bildircin, Fatma |
|
dc.contributor.author |
Karli, Pervin |
|
dc.contributor.author |
Avci, Bahattin |
|
dc.contributor.author |
Alper, Tayfun |
|
dc.contributor.author |
Ozdemir, Ayse Zehra |
|
dc.date.accessioned |
2022-03-08T08:38:04Z |
|
dc.date.available |
2022-03-08T08:38:04Z |
|
dc.date.issued |
2019 |
|
dc.identifier.citation |
Kayabas, H., Devran Bildircin, F., Avci, B., Karli, P., Zehra Ozdemir, A., & Alper, T. (2021). Serum amyloid-a may be an early marker in diagnosis of preterm premature rupture of membrane and chorioamnionitis . Annals of Medical Research |
en_US |
dc.identifier.uri |
http://hdl.handle.net/11616/54697 |
|
dc.description.abstract |
Aim: To determine the efficiency of serum amyloid-A (SAA) in predicting preterm premature rupture of membrane (PPROM) and chorioamnionitis in risky cases. Study Design: The study consists of 20 women 26-37 weeks of pregnancy who had PPROM and 20 pregnant women without water breaks. Levels of SAA were determined in maternal venous and umbilical cord blood. Results: SAA values in cord blood and venous blood of mothers with PPROM were higher than in the control group (p0,05). SAA values in the patients with clinical chorioamnionitis (n=9) were significantly higher (p0,05) than both PPROM patients without chorioamnionitis (n=11) and the control group (n=20). Conclusion: In women at risk for PPROM in whom diagnosis cannot be established, blood SSA levels can be used as a marker. Increased SAA values in pregnant women with PPROM who were conservatively treated were considered a marker for chorioamnionitis. |
en_US |
dc.language.iso |
eng |
en_US |
dc.rights |
info:eu-repo/semantics/openAccess |
en_US |
dc.title |
Serum amyloid-a may be an early marker in diagnosis of preterm premature rupture of membrane and chorioamnionitis |
en_US |
dc.type |
article |
en_US |
dc.relation.journal |
Annals of Medical Research |
en_US |
dc.contributor.department |
İnönü Üniversitesi |
en_US |